Company: ELV
Filing Date: 2025-03-28
Form Type: DEF 14A
Source: 0001156039-25-000046
Chunk: 66

Company: Elevance Health, Inc.
Filing Date: 2025-03-28
Form: DEF 14A
Chunk 66
---
                 |     — |     |                 |   |
| 3/1/2027        |     |              |   718 |     |     — |            |                    |     — |     |                 | 4,308 |     |                 |   |

(i) This column includes the unvested PSUs granted for the 2022-2024 performance period. The number of PSUs reported in this column reflects the number of shares earned for the 2022-2024 performance period, but the awards did not vest until March 1, 2025.

(3) These amounts are calculated by multiplying $368.90, the closing price of our common stock on December 31, 2024, by the applicable number of shares.

#### Option Exercises and Stock Vested
The following table provides information on the stock option exercises by, and shares acquired upon the vesting of PSUs and RSUs held by, our NEOs in 2024. Options exercised or vested PSUs and RSUs may or may not have been sold by a particular NEO, and the inclusion in this table of such information should not be understood to imply the actual receipt of money.

| Name            |     | Option Awards |        | Number of Shares Acquired on Exercise 
 (#)                                   | Value Realized Upon Exercise 
 ($)                          |     |   |           |     | Stock Awards(1) |        | Number of Shares Acquired on Vesting 
 (#)                                  | Value Realized On Vesting 
 ($)(2)                    |     |   |            |
|:----------------|:----|:--------------|-------:|:--------------------------------------|:-----------------------------|:----|:--|----------:|:----|:----------------|-------:|:-------------------------------------|:--------------------------|:----|:--|-----------:|
| Gail Boudreaux  |     |               |      — |                                       |                              |     |   |         — |     |                 | 43,588 |                                      |                           |     | $ | 22,394,028 |
| Mark Kaye       |     |               |      — |                                       |                              |     |   |         — |     |                 |  6,758 |                                      |                           |     | $ |  3,456,920 |
| Peter Haytaian  |     |               | 15,000 |                                       |                              |     | $ | 4,998,150 |